# Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer

> **NCT04464213** · PHASE1 · UNKNOWN · sponsor: **Beijing Tongren Hospital** · enrollment: 43 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **OTHER:** Single dose experiments
- **OTHER:** Multi-dose experiments

## Key facts

- **NCT ID:** NCT04464213
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464213, "Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04464213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*